JPMorgan Chase Agents $1.3B in Term Loans, Upsizing for Catalent
Catalent Pharma Solutions amended its existing credit agreement with JPMorgan Chase Bank as both administrative and collateral agent, to provide for, among other things, $950 million in incremental term loans and a $350 million increase to its revolver.
Read moreDetails










